Navigation Links
What U.S. Doctors Know That Has Not Yet Reached China
Date:10/22/2013

NEW YORK, Oct. 22, 2013 /PRNewswire/ -- Fibromyalgia (FM), a disorder now taken seriously in the United States after decades of misinformation and misdiagnosis, is still largely misunderstood and underdiagnosed by physicians in China. A recent national survey of Chinese rheumatologists revealed they have a lower awareness of FM compared with colleagues in Western countries. Sadly for China's patients with FM—a chronic disorder characterized by widespread musculoskeletal pain and fatigue—the dismissive attitude formerly directed at U.S. patients ("It's all in your mind!") is now being encountered by Chinese patients, just before they walk out of the doctor's office with no relief in sight.

An anonymous survey was conducted among a nationwide sample of Chinese rheumatologists at the 15th National Rheumatology Conference in 2010, with results published in the International Journal of Rheumatic Diseases this year. Of more than 700 respondents, 80 percent reported difficulties in treating FM patients. Nearly all—90.8 percent—mistakenly believed that the prognosis of FM patients was usually benign, and nearly 30 percent believed FM was only a psychological disorder. The investigators concluded that "awareness and perception of FM are still low among Chinese rheumatologists." There was some good news from the survey, however: "Our data also showed that most Chinese rheumatologists were eager for continuing medical education on FM."

In the U.S., people with FM who complained of "pain all over their bodies, constant fatigue and poor sleep" are no longer being told all they have is a psychological condition. Thanks to advanced medical technologies, most doctors here—both rheumatologists and other specialists—now have a deeper understanding as to how FM affects the body. However, with five million affected people in the U.S., the challenge is that treatment remains elusive. And there are still outstanding challenges as only half of this population is being treated.

Enter Seth Lederman, M.D., President and CEO of NYC-based TONIX Pharmaceuticals. The company's formulation, TNX-102 SL, is designed to help change FM treatment for millions of sufferers. Dr. Lederman and his team believe the key to easing the pain and suffering is enabling these patients to break the vicious cycle between poor sleep at night and pain during the day.

TONIX has taken cyclobenzaprine—an FDA-approved muscle relaxant that's been on the market for 35 years—and reformulated it as an under-the-tongue tablet taken at bedtime. This allows cyclobenzaprine to be taken up into the bloodstream rapidly, setting the tone for restorative sleep, which has been shown to mitigate pain experienced in FM.

Tonix recently announced the initiation of its Bedtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) clinical trial, which is the first of two pivotal trials for TNX-102 SL 2.8 mg tablets, in patients with FM. 

For more on TNX-102 SL and the BESTFIT trial, visit www.tonixpharma.com.

Contact:  Laura Radocaj, Dian Griesel Int'l., 212.825.3210


'/>"/>
SOURCE TONIX Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
2. Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online
3. Doctors at St. Josephs Hospital Stopping Atrial Fibrillation Cold
4. New Program Has Doctors, Patients Learn Together As Traditional Relationship Changes Forever
5. Eaton Scientific Discusses Positive Anecdotal Feedback from Pharmacist Compounding Homatropine for Doctors Treating Patients Experiencing Hot Flash Symptoms in the Beverley Hills and Los Angeles Area.
6. Latest Trend in Drug Manufacturer Sales Allows Doctors to Obtain Product Samples Online
7. Africa Needs Engineers as Much as Doctors to Save Lives, says South African Entrepreneur
8. Africa Needs Engineers as Much as Doctors to Save Lives, says South African Industrialist
9. The Japanese Cancer Association and Debiopharm Group Present Doctors Oshima and Tanaka with the 2012 JCA-Mauvernay Award for their Innovative and Outstanding Cancer Research
10. WebMD Study: U.S. Doctors Deeply Divided on Many Matters of Ethical Ambiguity
11. For Drug Manufacturers Bringing a New Product to Market, Gaining the Support of Influential Doctors Is a Mission-Critical Priority
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
Breaking Medicine News(10 mins):